CPPED1

Across TCGA pan-cancer cohorts, CPPED1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CPPED1 data layer compared with 23 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CPPED1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CPPED1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LUAD show a favorable association.

CCRCC, GBM, and COAD are the cancer types where CPPED1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	III,IV	1.000	0.797	.021	11	view →
GBM	OS	Quartile	All	0.428	0.785	.001	8	view →
COAD	DFS	Median	III,IV	0.897	1.000	.044	6	view →
LUAD	OS	Quartile	II,III,IV	0.936	0.498	.030	6	view →
LSCC	OS	Median	II,III,IV	0.873	0.700	.035	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CPPED1–CCRCC (OS)

Open the CCRCC breakdown →